BCM
BlueCrest Capital Management Portfolio holdings
AUM
$901M
1-Year Return
5.69%
This Quarter Return
+1.34%
1 Year Return
+5.69%
3 Year Return
+10.87%
5 Year Return
+26.99%
10 Year Return
+180.51%
AUM
$931M
AUM Growth
+$106M
(+13%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-20.68%
Top 10 Holdings %
Top 10 Hldgs %
40.75%
Holding
309
New
158
Increased
20
Reduced
23
Closed
63
Top Buys
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$75.3M |
| 2 |
Alibaba
BABA
|
$27.9M |
| 3 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
$25.6M |
| 4 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
$22.1M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
$21.6M |
Top Sells
Sector Composition
| 1 | Communication Services | 10.09% |
| 2 | Industrials | 7.15% |
| 3 | Financials | 7.07% |
| 4 | Consumer Discretionary | 5.03% |
| 5 | Real Estate | 3.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
New Jersey Resources
NJR
$4.7B
| $293K | 0.01% |
+5,500
| New | +$293K |
|
177
Valmont Industries
VMI
$7.45B
| $287K | 0.01% |
+900
| New | +$287K |
|
178
Murphy USA
MUSA
$7.21B
| $284K | 0.01% |
+1,100
| New | +$284K |
|
179
Reliance Steel & Aluminium
RS
$15.5B
| $282K | 0.01% |
1,100
-31,522
| -97% | -$8.09M |
|
180
Fair Isaac
FICO
$36.5B
| $281K | 0.01% |
+400
| New | +$281K |
|
181
Zymeworks
ZYME
$1.07B
| $280K | 0.01% |
+30,987
| New | +$280K |
|
182
Invesco Solar ETF
TAN
$730M
| $272K | 0.01% |
+3,503
| New | +$272K |
|
183
Pacific Biosciences
PACB
$372M
| $271K | 0.01% |
+23,400
| New | +$271K |
|
184
Deckers Outdoor
DECK
$18.4B
| $270K | 0.01% |
+3,600
| New | +$270K |
|
|
NARI
185
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $253K | 0.01% |
+4,100
| New | +$253K |
|
186
Idexx Laboratories
IDXX
$51.2B
| $250K | 0.01% |
+500
| New | +$250K |
|
|
LPTV
187
DELISTED
Loop Media, Inc.
LPTV
| $248K | 0.01% |
+43,054
| New | +$248K |
|
188
Global X US Preferred ETF
PFFD
$2.33B
| $243K | 0.01% |
+12,237
| New | +$243K |
|
189
ARK Web x.0 ETF
ARKW
$2.33B
| $241K | 0.01% |
+4,491
| New | +$241K |
|
190
Align Technology
ALGN
$9.76B
| $234K | 0.01% |
+700
| New | +$234K |
|
191
Zimmer Biomet
ZBH
$20.8B
| $233K | 0.01% |
+1,800
| New | +$233K |
|
192
Health Catalyst
HCAT
$232M
| $231K | 0.01% |
+19,800
| New | +$231K |
|
193
Boston Scientific
BSX
$159B
| $230K | 0.01% |
+4,600
| New | +$230K |
|
194
Enovis
ENOV
$1.8B
| $230K | 0.01% |
+4,300
| New | +$230K |
|
195
Merit Medical Systems
MMSI
$5.46B
| $229K | 0.01% |
+3,100
| New | +$229K |
|
196
Bruker
BRKR
$4.52B
| $229K | 0.01% |
+2,900
| New | +$229K |
|
197
Stryker
SYK
$151B
| $228K | 0.01% |
+800
| New | +$228K |
|
198
Transmedics
TMDX
$3.55B
| $227K | 0.01% |
+3,000
| New | +$227K |
|
199
Outset Medical
OM
$237M
| $226K | 0.01% |
+820
| New | +$226K |
|
200
Hologic
HOLX
$14.8B
| $226K | 0.01% |
+2,800
| New | +$226K |
|